Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients

Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients

Abstract With the changing epidemiology of COVID-19 and its impact on our daily lives, there is still an unmet need of COVID-19 therapies treating early infections to prevent progression. The current study was a randomized, parallel, double-blind, placebo-controlled trial. Ninety SARS-CoV-2 positive...

Full description

Bibliographic Details
Main Authors: Jens Peter Klussmann, Maria Grosheva, Peter Meiser, Clara Lehmann, Eszter Nagy, Valéria Szijártó, Gábor Nagy, Robert Konrat, Michael Flegel, Frank Holzer, Dorothea Groß, Charlotte Steinmetz, Barbara Scherer, Henning Gruell, Maike Schlotz, Florian Klein, Paula Aguiar de Aragão, Henning Morr, Helal Al Saleh, Andreas Bilstein, Belisa Russo, Susanne Müller-Scholtz, Cengizhan Acikel, Hacer Sahin, Nina Werkhäuser, Silke Allekotte, Ralph Mösges
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32546-z

Internet

https://doi.org/10.1038/s41598-023-32546-z

Similar Items